Other investors include Chinese-listed biotech firm 3SBio’s subsidiary Sunshine Guojian and Eisai Co Ltd. The post MUFG Capital joins Zurich-based Numab Therapeutics’ $22.6m Series B appeared first on DealStreetAsia.